Introduction: Who Should Seek Diagnostic Testing

If you suddenly lose vision in one eye without any pain, you need to seek medical attention immediately. This is not something that can wait until tomorrow or even a few hours. Retinal artery occlusion happens when a blood vessel carrying oxygen to your retina becomes blocked, and the nerve cells in your eye begin to suffer from lack of oxygen within minutes.^[1]

Anyone experiencing sudden, painless vision loss should be evaluated as quickly as possible. The condition most commonly affects people in their 60s, particularly men, and those with high blood pressure or diabetes. However, it can happen to anyone. Think of it like a stroke in your eye—just as a stroke in the brain requires immediate attention, so does a blockage in the retinal artery. The faster you get help, the better your chances of preserving whatever vision remains.^[2]

You might notice your vision suddenly becomes completely dark in one eye, or you might see only part of your visual field disappear. Some people describe it as a curtain being pulled across their vision. Others experience severe blurring that makes it impossible to see clearly. In some cases, these symptoms last only seconds or minutes before vision returns temporarily—a warning sign called amaurosis fugax that should never be ignored because it can signal an impending permanent blockage.^[3]

People with certain risk factors should be especially alert to the possibility of retinal artery occlusion. If you have high blood pressure, diabetes, high cholesterol, heart disease, irregular heart rhythms like atrial fibrillation, or carotid artery disease in your neck, you’re at higher risk. Smokers and people who are overweight also face increased chances of developing this condition. Women taking birth control pills may have a slightly elevated risk as well.^[4]

Classic Diagnostic Methods

When you arrive at the emergency room or eye doctor’s office with sudden vision loss, the diagnostic process begins immediately. The first and most important test is a comprehensive eye examination. Your doctor will dilate your pupil using special eye drops so they can see the back of your eye clearly. This allows them to examine your retina and the blood vessels that feed it.^[2]

During this dilated eye examination, doctors look for specific signs that indicate a retinal artery is blocked. The most characteristic finding is called a cherry red spot. This appears as a small red dot in the center of your macula—the part of your retina responsible for sharp, central vision. The area around this red spot looks pale or whitish because the retinal tissue is not receiving enough blood and oxygen. This cherry red spot is so distinctive that it often allows doctors to diagnose central retinal artery occlusion immediately just by looking at it.^[2]

If a smaller branch of the retinal artery is blocked rather than the main artery, the appearance is slightly different. Doctors will see an area of pale, whitish retina along the path of the blocked blood vessel. This whitening shows where the retinal tissue is being starved of oxygen. The whitening pattern typically lasts between four to six weeks before gradually fading, even though the damage to the retina may be permanent.^[2]

Fluorescein angiography is another important diagnostic test. During this procedure, a special dye called fluorescein is injected into a vein in your arm. The dye travels through your bloodstream and reaches the blood vessels in your eye. A camera with special filters takes rapid photographs as the dye passes through your retinal blood vessels. When an artery is blocked, the dye cannot flow through normally, and doctors can see exactly where the blockage is located and how severely blood flow is affected. The test shows a delay in the filling of the retinal arteries, confirming the diagnosis and helping doctors understand the extent of the blockage.^[2]

Optical coherence tomography, often abbreviated as OCT, is a sophisticated imaging test that provides incredibly detailed cross-sectional images of your retina. Think of it as an ultrasound for your eye, but using light waves instead of sound waves. The OCT machine scans your retina layer by layer, creating images that show swelling in the inner layers of the retina where oxygen deprivation has occurred. Over time, follow-up OCT scans can show how these swollen areas eventually become much thinner than normal as the damaged tissue shrinks—a process called atrophy.^[2]

Your doctor will also perform several basic but important tests. A visual acuity test measures how well you can see using an eye chart. This establishes a baseline and helps track whether your vision improves or worsens over time. A visual field examination maps out which areas of your vision are affected. Your doctor will check how your pupils react to light, test the pressure inside your eye, and use a special microscope called a slit lamp to examine the structures in the front of your eye.^[3]

Beyond examining your eye, doctors need to understand what caused the blockage. This means investigating your cardiovascular system. Your blood pressure will be measured to check for hypertension. Blood tests will look at your cholesterol and triglyceride levels, blood sugar levels to screen for diabetes, and sometimes your blood’s tendency to clot. An erythrocyte sedimentation rate test may be ordered to check for inflammation that could indicate a rare but serious condition called giant cell arteritis.^[3]

To find the source of a blood clot or blockage, your doctor may order several heart-related tests. An electrocardiogram (ECG) records your heart’s electrical activity to detect irregular rhythms. An echocardiogram uses sound waves to create moving pictures of your heart, showing whether there are problems with your heart valves or if blood clots have formed in the heart chambers. You may need to wear a heart monitor for a day or longer to detect irregular heart rhythms that come and go.^[3]

The carotid arteries in your neck are common sources of clots that travel to the eye. A Duplex Doppler ultrasound of the carotid arteries uses sound waves to create images of these blood vessels and measure blood flow through them. This painless test can reveal narrowing or blockages in the carotid arteries caused by fatty deposits. In some cases, doctors might order more detailed imaging like a CT scan or MRI of your head and neck to get a complete picture of your blood vessels.^[3]

Diagnostics for Clinical Trial Qualification

When patients with retinal artery occlusion are being considered for enrollment in clinical research trials, additional diagnostic criteria and tests become important. Clinical trials investigating treatments for this condition typically require very specific documentation of when symptoms began and what the baseline vision measurement was at the time of diagnosis.^[6]

The precise timing of symptom onset is critical for clinical trial eligibility. Most research studies investigating acute treatments for retinal artery occlusion only include patients who can be treated within a specific time window, often within 4 to 6 hours or up to 24 hours from when vision loss first occurred. This strict time requirement reflects the understanding that treatments aimed at restoring blood flow must be given quickly before permanent damage occurs to the oxygen-starved retinal cells.^[6]

Clinical trials typically require confirmation of the diagnosis through multiple methods. This means patients must have both the characteristic appearance of retinal artery occlusion seen on dilated eye examination and confirmation through imaging tests like fluorescein angiography or OCT. The fluorescein angiography is particularly valuable in clinical trials because it provides objective, documented evidence of delayed arterial filling and can be compared before and after treatment to measure whether blood flow has improved.^[2]

Baseline visual acuity measurements are standardized in clinical trials. Rather than using a simple eye chart, research protocols typically employ specific standardized vision testing charts and precise measurement techniques. These baseline measurements are crucial because the main goal of treatment studies is to determine whether an intervention can improve vision compared to what happens without treatment. Without accurate baseline measurements, it would be impossible to know whether any improvement occurred.^[6]

Classification of the type of retinal artery occlusion matters for trial enrollment. Studies distinguish between central retinal artery occlusion (where the main artery is blocked) and branch retinal artery occlusion (where only a smaller branch is affected). They also differentiate between arteritic cases (caused by inflammation of the artery, particularly giant cell arteritis) and nonarteritic cases (caused by blood clots or cholesterol deposits). Most treatment trials focus specifically on nonarteritic central retinal artery occlusion because arteritic cases require different treatment approaches with steroid medications.^[1]

About 25 percent of people have an extra small artery called a cilioretinal artery that supplies blood to part of the central retina. Clinical trials need to document whether this artery is present and functioning because its presence can significantly protect central vision even when the main retinal artery is blocked. Patients with a functioning cilioretinal artery often have better visual outcomes, which can affect study results and interpretation.^[2]

Trials investigating treatments for retinal artery occlusion require comprehensive cardiovascular evaluation to ensure patient safety. This includes detailed assessment of bleeding risk factors, since some experimental treatments involve blood thinners or clot-dissolving drugs. Patients with recent strokes, brain bleeding, uncontrolled high blood pressure, or conditions that increase bleeding risk are typically excluded from trials using these medications because the risks would outweigh potential benefits.^[6]

Clinical research protocols also require thorough documentation of any underlying causes of the blockage. This means extensive testing to identify potential sources of blood clots, including assessment of heart valve disease, irregular heart rhythms, carotid artery disease, and blood clotting disorders. Understanding these underlying causes helps researchers analyze whether treatments work better or worse in patients with specific risk factors.^[5]

Follow-up diagnostic testing schedules are more intensive in clinical trials than in routine clinical care. Participants typically undergo repeated OCT scans, visual field testing, and vision measurements at specific intervals—often at one week, one month, three months, and six months after treatment. This systematic follow-up allows researchers to track the natural history of the condition and measure whether treatments affect the progression of damage or the development of complications.^[6]